Cytokine gene polymorphisms and acute human liver graft rejection

Liver Transplantation

Volumn 8, Issue 7, 2002, Pages 603-611

  Warlé, Michiel C ^a   Farhan, Ayar ^a   Metselaar, Herold J ^a   Hop, Wim C J ^a   Perrey, Chris ^a   Zondervan, Pieter E ^b   Kap, Marcel ^a   De Rave, Sjoerd ^a   Kwekkeboom, Jaap ^a   IJzermans, Jan N M ^a   Tilanus, Hugo W ^a   Pravica, Vera ^a   Hutchinson, Ian V ^a   Bouma, Gerda J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE; DNA; GAMMA INTERFERON; HLA DR6 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PREDNISOLONE; PREDNISONE; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR DERIVATIVE; LYMPHOTOXIN;

ACUTE DISEASE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GRAFT REJECTION; HLA TYPING; HUMAN; HUMAN CELL; INFORMED CONSENT; LIVER BIOPSY; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTPATIENT DEPARTMENT; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TH1 CELL; TH2 CELL; ADULT; FEMALE; GENETIC PREDISPOSITION; GENETICS; HELPER CELL; IMMUNOLOGY; MALE; MIDDLE AGED; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADULT; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; HLA-DR6 ANTIGEN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; LIVER TRANSPLANTATION; LOGISTIC MODELS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036019567     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.33967     Document Type: Article

References (60)

1. Immunosuppressive drugs in renal transplantation
2. Malignancy
3. Infectious complications in liver transplant recipients on tacrolimus: Prospective analysis of 88 consecutive liver transplants
4. Metabolic complications after liver transplantation: Diabetes, hypercholesterolemia and obesity
5. The role of tumor necrosis factor in allograft rejection
6. Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplification
7. Cytokines as mediators of organ graft rejection and tolerance
8. Plasma levels of tumor necrosis factor and soluble TNF receptors in kidney transplant recipients
9. In vitro cytokine profiles and their relevance to rejection following renal transplantation
10. Cytokine pattern during rejection and infection after liver transplantation-Improvements in postoperative monitoring?
11. Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection
12. In vitro cytokine production of TNFalpha and IL-13 correlates with acute liver transplant rejection
13. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long surviving mouse heart allografts after brief CD4-monoclonal antibody therapy
14. High frequency of IL-10-secreting CD4+ graft infiltrating T lymphocytes on promptly rejected kidney allografts
15. Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts
16. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation
17. Low level of interleukin 10 synthesis during liver allograft rejection
18. Evaluation of sequential serum interleukin-6 levels in liver allograft recipients
19. Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation
20. Intragraft cytokine profile during human liver allograft rejection
21. The expanding universe of T cell subsets: Th1, Th2 and more
22. TGF-β1: Immunosuppressant and viability factor for T lymphocytes
23. Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allografts
24. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection
25. A genetic marker of high TNF-α production in heart transplant recipients
26. ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms
27. Cytokine gene polymorphism and heart transplant rejection
28. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation
29. Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients
30. The effect of polymorphisms in tumor necrosis factor-α, interleukin-10, and transforming growth factor-β1 genes in acute hepatic allograft rejection
31. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation
32. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
33. Genetic influence on cytokine production and fatal meningococcal disease
34. Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation
35. No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation
36. A study of cytokine gene polymorphisms and protein secretion in renal transplantation
37. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients
38. An investigation of polymorphism in interleukin-10 gene promoter
39. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
40. Effector mechanisms in allograft rejection
41. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes
42. Genotypic variation in the transforming growth factor-β1 gene
43. Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage
44. Association of a Leu(10)-Pro polymorphism of the transforming growth factor-β1 with genetic susceptibility to osteoporosis and spinal osteoarthritis
45. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression
46. In vivo expression of transforming growth factor-β1 in humans
47. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants
48. HLA-DRw6-positive recipients are high responders in renal transplantation
49. Poor kidney-graft survival in recipients with HLA-DRw6
50. Effect of the HLA-DRw6 antigen in liver transplantation
51. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules
52. Fibrosis in chronic rejection of human liver allografts
53. Renal failure after clinical heart transplantation is associated with the TGF-β1 codon 10 gene polymorphism
54. Polymorphism of the transforming growth factor-β1 gene correlates with the development of coronary vasculopathy following cardiac transplantation
55. Expression of cytokine genes in human cardiac allografts: Correlation of IL-6 and transforming growth factor-beta (TGF-β) with histological rejection
56. Bcl-2 blocks apoptotic signal of transforming growth factor-β in human hepatoma cells
57. Apoptosis as a mechanism of cell death in liver allograft rejection
58. A single nucleotide polymorphism in the first intron of the human IFNγ gene
59. CA repeat allele polymorphism in the first intron of the human interferon-γ gene is associated with lung allograft fibrosis
60. Association of polymorphisms in the human interferon-γ and interleukin-10 gene with acute and chronic kidney transplant outcome